| ROS, cell senescence, and novel molecular mechanisms in aging and age‐related diseases P Davalli, T Mitic, A Caporali, A Lauriola, D D’Arca Oxidative medicine and cellular longevity 2016 (1), 3565127, 2016 | 969 | 2016 |
| The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain X Zhao, D D'Arca, WK Lim, M Brahmachary, MS Carro, T Ludwig, ... Developmental cell 17 (2), 210-221, 2009 | 176 | 2009 |
| The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression A Caporali, P Davalli, S Astancolle, D D'Arca, M Brausi, S Bettuzzi, A Corti Carcinogenesis 25 (11), 2217-2224, 2004 | 172 | 2004 |
| Clusterin (SGP‐2, ApoJ) expression is downregulated in low‐and high‐grade human prostate cancer M Scaltriti, M Brausi, A Amorosi, A Caporali, D D'Arca, S Astancolle, ... International journal of cancer 108 (1), 23-30, 2004 | 136 | 2004 |
| Targeting oxidatively induced DNA damage response in cancer: opportunities for novel cancer therapies P Davalli, G Marverti, A Lauriola, D D’Arca Oxidative medicine and cellular longevity 2018 (1), 2389523, 2018 | 106 | 2018 |
| Huwe1 ubiquitin ligase is essential to synchronize neuronal and glial differentiation in the developing cerebellum D D’Arca, X Zhao, W Xu, NC Ramirez-Martinez, A Iavarone, A Lasorella Proceedings of the National Academy of Sciences 107 (13), 5875-5880, 2010 | 95 | 2010 |
| Anticancer activity of green tea polyphenols in prostate gland P Davalli, F Rizzi, A Caporali, D Pellacani, S Davoli, S Bettuzzi, M Brausi, ... Oxidative Medicine and Cellular Longevity 2012 (1), 984219, 2012 | 81 | 2012 |
| Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin AE Caccamo, M Scaltriti, A Caporali, D D'arca, F Scorcioni, S Astancolle, ... Biochemical Journal 382 (1), 157-168, 2004 | 78 | 2004 |
| Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance L Taddia, D D’Arca, S Ferrari, C Marraccini, L Severi, G Ponterini, ... Drug Resistance Updates 23, 20-54, 2015 | 74 | 2015 |
| Ca2+ depletion induces nuclear clusterin, a novel effector of apoptosis in immortalized human prostate cells AE Caccamo, M Scaltriti, A Caporali, D D'Arca, A Corti, D Corvetta, A Sala, ... Cell Death & Differentiation 12 (1), 101-104, 2005 | 66 | 2005 |
| Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke S Carnevali, F Luppi, D D'Arca, A Caporali, MP Ruggieri, MV Vettori, ... American journal of respiratory and critical care medicine 174 (4), 393-399, 2006 | 55 | 2006 |
| Nuclear translocation of a clusterin isoform is associated with induction of anoikis in SV40‐immortalized human prostate epithelial cells AE CACCAMO, M Scaltriti, A Caporali, D D'ARCA, F Scorcioni, ... Annals of the New York Academy of Sciences 1010 (1), 514-519, 2003 | 51 | 2003 |
| MITOSTATIN, a putative tumor suppressor on chromosome 12q24. 1, is downregulated in human bladder and breast cancer A Vecchione, M Fassan, V Anesti, A Morrione, S Goldoni, G Baldassarre, ... Oncogene 28 (2), 257-269, 2009 | 50 | 2009 |
| Repurposing of drugs targeting YAP-TEAD functions GM Elisi, M Santucci, D D’Arca, A Lauriola, G Marverti, L Losi, L Scalvini, ... Cancers 10 (9), 329, 2018 | 45 | 2018 |
| Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5-year follow-up study S Bettuzzi, M Scaltriti, A Caporali, M Brausi, D D’Arca, S Astancolle, ... Cancer research 63 (13), 3469-3472, 2003 | 34 | 2003 |
| Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells M Fassan, D D'Arca, J Letko, A Vecchione, MP Gardiman, P McCue, ... PLoS One 6 (5), e19771, 2011 | 28 | 2011 |
| Optimization of peptides that target human thymidylate synthase to inhibit ovarian cancer cell growth M Pelà, P Saxena, R Luciani, M Santucci, S Ferrari, G Marverti, ... Journal of Medicinal Chemistry 57 (4), 1355-1367, 2014 | 27 | 2014 |
| Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor D D'Arca, J LeNoir, B Wildemore, F Gottardo, E Bragantini, ... Urologic Oncology: Seminars and Original Investigations 28 (2), 189-194, 2010 | 23 | 2010 |
| Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery F Sacchetti, C Marraccini, D D’Arca, M Pelà, D Pinetti, E Maretti, ... Colloids and Surfaces B: Biointerfaces 136, 346-354, 2015 | 22 | 2015 |
| Folic Acid–Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting G Marverti, C Marraccini, A Martello, D D’Arca, S Pacifico, R Guerrini, ... Journal of medicinal chemistry 64 (6), 3204-3221, 2021 | 20 | 2021 |
